«Paralysis

Below is an extended Paralysis patents listing. Click here to return to the Paralysis main in depth entry.

Patents :
US Patent No.	Title
7411051	Antibodies to HDPPA04 polypeptide
7419501	Integrated mechanical handle with quick slide mechanism
7419670	Method of treating arthritis with SERP-1 and an immunosuppressant
7419674	Alpha virus-based cytomegalovirus vaccines
7419675	Method for treating peritoneal adhesions
7419676	Activatable recombinant neurotoxins
7419816	Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS
7419826	Human schwannoma cell line
7420033	Composition of lactoferrin related peptides and uses thereof
7420472	Patient monitoring apparatus
7422753	Methods for treating trichotillomania
7418292	Device and method for attenuating an immune response
7417121	Human G-protein coupled receptor, HGPRBMY39
7417025	Use of poly-.alpha.2,8-sialic acid mimetic peptides to modulate NCAM functions
7411052	Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
7411054	25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
7411069	Doxepin analogs and methods of use thereof
7411509	System and method for observing patients in geographically dispersed health care locations
7412978	Augmentation and repair of vocal cord tissue defects
7413742	Clostridial toxin derivatives and methods for treating pain
7413781	Gels for encapsulation of biological materials
7414139	Catalytic antioxidants and methods of use
7414173	Isolated nucleic acid molecules encoding orally active androctonus amoreuxi pesticidal biopeptides
7416747	Herbal composition for treatment of neurodegeneration and neuronal dysfunction
7422862	Methods for identifying modulators of apoptosis
7422877	Activatable recombinant neurotoxins
7427469	Method of treating cytomegalovirus with DC-SIGN blockers
7427606	Method to reduce inflammatory response in transplanted tissue
7427628	Heterocyclic compounds which inhibit leukocyte adhesion mediated by .alpha..sub.4 integrins
7429238	Systems and methods for the generation of crystalline polymorphs
7429267	Device and method using integrated neuronal cells and an electronic device
7429375	Proteoglycan degrading mutants for the treatment of CNS
7429386	Stretch mark treatment
7429482	Screening tools for discovery of novel anabolic agents
7429575	N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use
7429609	Pyrazole compound and medicinal composition containing the same
7427404	Pertussis toxin mutants, bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines
7426445	Measuring temperature change in an electronic biomedical implant
7425610	Methods and materials relating to CD84-like polypeptides and polynucleotides
7422890	Therapeutic and prophylactic agents and methods of using the same
7422900	System and method for forming a connective tissue construct
7423024	Recombinant human alpha-fetoprotein as an immunosuppressive agent
7423194	Animal models for demyelination disorders
7425324	Antagonists of MCP proteins
7425332	Treatment of autoimmune conditions with Copolymer 1 and related Copolymers
7425337	Alphavirus replicon vector systems
7425338	Clostridial toxin derivatives and methods for treating pain
7425437	Vaccines against West Nile Virus
7425541	Enzyme-cleavable prodrug compounds
7429618	Potassium channel modulators

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.